News
March 22, 2007 — Pfizer says the FDA has approved the company’s Lipitor (atorvastatin calcium) Tablets to reduce the ...
March 21, 2007
News
March 22, 2007 — Edwards Lifesciences Corp. says it has received conditional FDA approval to initiate a pivotal clinical ...
March 21, 2007Feature | Larry Sieb
Cardiac exams represent only about five percent of all CT procedures, but cardiac CT continues to generate the most interest at manufacturers’ exhibits as seen at the 2006 RSNA Annual Scientific Meeting. The fascination with Cardiovascular Computed Tomography (CVCT) remains high even though full reimbursement is not expected to occur until 2009, according to industry observers at RSNA.
March 21, 2007Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
March 22, 2007 — McKesson has announced it has expanded its distribution agreement with Toshiba America Medical Systems ...
March 21, 2007News
March 22, 2007 — MedicalCV Inc. has announced it has received FDA clearance for its SOLAR Surgical Ablation System for ...
March 21, 2007News
March 22 2007 — ZOLL Medical Corp announced today it received FDA clearance to market and sell the ZOLL M Series with ...
March 21, 2007Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Feature | Craig Walker, M.D., with contributions from Vinod Nair, M.D.
The application of computed tomography in cardiovascular practice has utilized electron beam computed tomography (EBCT) and multidetector computed tomography (MDCT). Both are useful for calcium scoring; however, the superior spatial resolution of MDCT has made it the dominant modality in arterial imaging.
March 21, 2007News
March 22, 2007 — St. Jude Medical Inc. says it has received FDA approval of a new cardiac rhythm management device ...
March 21, 2007News
March 22, 2007 — Evalve, Inc., a privately held medical device company, has announced the FDA has approved a registry of up to 70 patients who are at high risk of mortality from surgical treatment for mitral regurgitation (MR) as part of its ongoing pivotal EVEREST Study (Endovascular Valve Edge-to-Edge REpair STudy).
March 21, 2007Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Feature | Archana Swathy
The modern world of medicine has been revolutionized by the inception of minimally invasive interventional techniques ...
March 21, 2007
Technology
MasterScreen CPX is reportedly a complete exercise test that includes a stress ECG option. Its digital TripleV volume ...
March 20, 2007
Technology
Voxar 3-D 6.1 visualization and analysis software incorporates a suite of clinical applications for CT cardiac analysis ...
March 20, 2007Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Technology
The Human Patient Simulator (HPS) – a computer-model-driven, full-sized mannequin – delivers experience in true-to-life ...
March 20, 2007
Technology
The Avanta Fluid Management Injection System is intended to help cardiovascular healthcare professionals improve patient ...
March 20, 2007
Technology
Cholestech Corp., provider of point-of-care health management solutions for chronic disease, and Life Line Screening ...
March 20, 2007© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now